Green Data Cabinets Feature Editorial

One of the largest cogeneration facilities in Portugal, Galp Energia's Matosinhos Cogeneration Plant near Porto, has selected GE's two Frame 6B gas turbines to replace older oil-fired technology at the site. Apart from increasing the plant's efficiency, these gas turbines will also help Galp Energia to abide by the government regulations.

GE's worldwide installed fleet totals more than 6,000 gas turbines, the largest installed base of any gas turbine supplier. These units have accumulated well over 200 million fired hours of operating experience at unparalleled reliability levels.

Apart from enabling Galp Energia to produce electricity and sell it to Portugal's national grid, the Frame 6B gas turbines are expected to provide all of the steam requirements for the nearby Galp Energia's Matosinhos refinery. The consortium Ensulmeci-Efacec Cogeraçao do Porto, ACE will now develop the Matosinhos cogeneration turnkey project is being developed for Galp Energia.

"Nearly 50 GE Frame 6B gas turbines have been committed or installed for cogeneration projects throughout the Iberian region, including the Matosinhos and Sines plants," said Ricardo Cordoba, president of GE Energy for Western Europe and North Africa. "The Frame 6B delivers both excellent reliability and versatility, as well as an ability to run in complex load situations and on a variety of fuels."

Looking to modernize power and steam production for its refineries in Portugal, Galp Energia has selected the new gas turbines as the third and fourth GE 6B gas turbines. The first two 6B machines recently entered commercial operation at a cogeneration plant that supports the Sines petrochemical industrial park. GE's scope of supply for the Matosinhos project also includes gas turbine auxiliary equipment, technical advisory and training services.

Recently, CCS Medical, Inc., a premier provider of medical supplies received a $35 million revolving line of credit facility from GE Capital, Healthcare Financial Services. Following CCS Medical's exit from Chapter 11 bankruptcy protection on March 31, the loan will be used to refinance existing debt, provide working capital and support growth initiatives, stated the company.